stocksbrew

RARERARE

Keep

Keep what you own, but don't buy more for now.

  • 2 good· Wider margin
  • 8 to watch· Earnings miss

$16.33−0.38 (−2.25%)

Price at 3:01 PM ET

After hours · opens in 17h 23mNext open: Friday, Nov 13, 9:30 AM ET

Healthcare · Small company

Read the full report on RARE with a free account

The full report adds the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

Could move it to Buy more

Next report

  • above15%

    sales growth

Any one could move it to Sell some

Next report

  • below8%

    sales growth

Compared with the S&P 500

  • 26 points

    worse in one day

  • 59 points

    worse in five trading days

−48.9% in a year

Earnings report

Latest results

Reported Nov 3 after the close
EPS
−$1.16
vs −$1.15 expected, in line
The stock
+3.2%
On Nov 4, usually 3.4%

The news behind our call

written Oct 27, 3:11 AM ETOct 27, 3:11 AM ET · 1 articles · 1 sources

What changed

From Yahoo Finance and Yahoo Finance Singapore
  1. Ultragenyx to Participate at investor Conferences in London

    Yesterday

  2. Ultragenyx announces the marketing authorisation application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type a) is under Review with the UK Medicines and Healthcare Products Regulatory Agency

    Friday

  3. What Ultragenyx Pharmaceutical (RARE) said on its Q3 earnings call

    Nov 3

  4. RARE reported earnings

    Earnings · Nov 3

  5. Analyst ratings shifted: 1 more hold

    10 buy, 11 hold, 0 sell, against 10 buy, 10 hold, 0 sell the month before.

    Analysts · Last month

  6. USA Rare Earth, Inc. (USAR) stock price, news, quote and history

    Oct 26

  7. Analyst ratings shifted: 8 fewer buy, 8 more hold

    10 buy, 10 hold, 0 sell, against 18 buy, 2 hold, 0 sell the month before.

    Analysts · Sep

  8. Gilbert Cisneros bought RARE

    House, D-CA. Amount $1K to $15K.

    Congress · Sep 29

Overview

In plain numbers

  • Revenue grew 15.8% from a year earlier, to $730.0M in the last twelve months.
  • It loses 60 cents on every revenue dollar at the operating line, up from a loss of $1.09 in FY 2021.
  • It burned $442.0M of free cash in the last twelve months.
  • It owes $1.2B and holds $401.0M in cash and investments, so net debt is $785.0M.

Key figures

Revenue (TTM)
$730M
Revenue growth, 1 year
+15.8%
Net income
−$524M
EPS (diluted)
−$5.18
Gross margin
-10.7%
Operating margin
-59.9%
Return on capital
-32.2%
Current ratio
1.40
Buyback yield
-3.70%

Revenue by region

period ending Jun 30, 2026
  • North America$396M · 55%
  • Latin America$175M · 24%
  • Europe$124M · 17%
  • Japan$21.5M · 3.0%

Key facts

Company value
$1.6B
Today's range
16.2316.61
Past year's range
12.8836.54
Yesterday's close
$16.70
Swings vs the market
0.3×smaller
After hours

That's a wrap.

17hrs23min33sec

Market opens Friday, Nov 13 at 9:30 AM ET